ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,864.67
0.40%
Dow Jones
43,275.91
0.09%
US Dollar vs MXN
19.88545
0.32%
Brent Oil
72.92
-1.67%
Bitcoin
68,612.40
1.77%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
18/10/202415:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GS-DGoldman Sachs Group Inc
18/10/202415:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:WITWipro Ltd
18/10/202415:05Edgar (US Regulatory)Form 305B2 - Filing [Trust Indenture Act]NYSE:HIIHuntington Ingalls Industries Inc
18/10/202415:05Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:FFNWFirst Financial Northwest Inc
18/10/202415:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BFYWBetter For You Wellness Inc (PK)
18/10/202415:05Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:EUDAWEuda Health Holdings Ltd
18/10/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIPOLipella Pharmaceuticals Inc
18/10/202415:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GLACRGlobal Lights Acquisition Corporation
18/10/202415:05Business WireSavara Announces New Employment Inducement GrantNASDAQ:SVRASavara Inc
18/10/202415:05Business WireFlux Power Receives Non-Compliance Letter from NasdaqNASDAQ:FLUXFlux Power Holdings Inc
18/10/202415:05Business WirePublic Storage Announces Hiring of Chris Sambar as Chief Operating OfficerNYSE:PSAPublic Storage
18/10/202415:05PR Newswire (US)Noble Corporation plc to announce third quarter 2024 resultsNYSE:NENoble Corporation PLC
18/10/202415:05GlobeNewswire Inc.Nasdaq Resumes Trading in Nebius Group N.V.NASDAQ:NDAQNasdaq Inc
18/10/202415:05GlobeNewswire Inc.Navitas’ new ‘IntelliWeave’ Control Technique Powers Next-Gen AI Data Centers above 99% EfficiencyNASDAQ:NVTSNavitas Semiconductor Corporation
18/10/202415:04Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
18/10/202415:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BWMNBowman Consulting Group Ltd
18/10/202415:04PR Newswire (Canada)Strike by store employees - The SAQ reacts to the SEMB's decision and implements its business continuity plan
18/10/202415:03Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:OTRKPOntrak Inc (PK)
18/10/202415:03Edgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]NASDAQ:PSECProspect Capital Corporation
18/10/202415:01Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CNTACentessa Pharmaceuticals PLC
18/10/202415:01PR Newswire (US)Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation SystemNYSE:BSXBoston Scientific Corporation
18/10/202415:01GlobeNewswire Inc.Zefiro Methane Corp. Highlights Commercial Momentum on Live Investor CallNEO:ZEFIZefiro Methane Corp
18/10/202415:01GlobeNewswire Inc.Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:CAPRCapricor Therapeutics Inc
18/10/202415:01GlobeNewswire Inc.Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of ConceptNASDAQ:EDITEditas Medicine Inc
18/10/202415:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:LANVLanvin Group Holdings Limited
18/10/202415:00The Daily HodlEthereum Whales Gobble Up 1,700,000 ETH in Just 30 Days, Signaling Confidence: IntoTheBlockCOIN:FETUSDFetch
18/10/202415:00Edgar (US Regulatory)Form SEC STAFF ACTION - SEC Staff Action: ORDERNASDAQ:NCNCWnoco noco Inc
18/10/202415:00GlobeNewswire Inc.Survival, Struggle, and the American Dream: One Jewish Family’s Story On Manhattan’s Lower East Side At The Turn Of The Century
18/10/202415:00GlobeNewswire Inc.XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:XRTXXORTX Therapeutics Inc
18/10/202415:00Business WireUnited Security Bancshares Reports Third Quarter 2024 EarningsNASDAQ:UBFOUnited Security Bancshares

Su Consulta Reciente

NYSE
KO
Coca Cola
NASDAQ
NVDA
NVIDIA
FX
EURUSD
Euro vs US Dollar
NASDAQ
TSLA
Tesla
NYSE
BAC
Bank of America
COIN
AVAXUSD
Avalanche
COIN
ADAUSD
Cardano
NYSE
MCD
McDonalds
USI
USTECH100
US Tech 100
NYSE
VZ
Verizon Communications
COIN
DOGEUSD
Dogecoin
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US30
US 30
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados